Solara Active Pharma Sci Share Price

Solara Active Pharma Sci Share Price

NSE: SOLARA
|
Pharmaceuticals
|
S Cap
₹ 722.90
-₹21.65 (-2.91%)
1D
Last updated 23 Sep, 2026, 15:50 IST

Solara Active Pharma Sci Share Price Today

As of 24 Sep 2026, Solara Active Pharma Sci share price is ₹722.90. The stock opened at ₹744.55, compared to its previous close of ₹744.55. During today's trading session, Solara Active Pharma Sci share price moved in the range of ₹715.00 to ₹759.50, with an average price of ₹737.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹422.00 and a high of ₹774.00. On the performance front, Solara Active Pharma Sci share price has increased by 66.45% over the last six months and is up 10.21% on a year-on-year basis.

₹715.00
2.91% down today
₹759.50
1D LOW
1D HIGH

Solara Active Pharma Sci Returns Calculator

Circuit
L
H
₹595.65
₹893.45
52-week
L
H
₹422.00
₹774.00

About Solara Active Pharma Sci

Solara Active Pharma Sci Share Price
ISIN
INE624Z01016
Sector Market Cap
₹ 3,615.16 Cr

Solara Active Pharma Sciences Limited is an India-based global, pureplay active pharmaceutical ingredients (API) company. The Company is engaged in the manufacturing and development of APIs and offers contract manufacturing and development services for global companies. Its commercial product category includes Albendazole, Aprepitant (Antiemetic), Colchicine, Citicoline Sodium, Disulfiram, Dolutegravir, Etomidate, Flucytosine, Ibuprofen Arginine, Lurasidone Hydrochloride, Rifaximin, Tioconazole, Zileuton and others. Its research and development (R&D) product category includes Brivaracetam, Flecainide Acetate, Naproxen Base, Obeticholic acid, Patiromer Sorbitex Calcium, Rotigotine, Safinamide, Sapropterin, Sugammadex, Tranexamic Acid, Sucroferric Oxyhydroxide and others. Its business is spread across 70 countries with operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. It has one R&D center in Chennai.

Solara Active Pharma Sci Financial Highlights

  • Revenue: Solara Active Pharma Sci reported revenue of ₹1,375.14 crore in FY26 vs ₹1,292.08 crore in FY25. It showed an increase of 6.43% on a yearly basis.
  • Operating Profit: Solara Active Pharma Sci reported an operating loss of ₹7.41 crore in FY26 vs ₹0.54 crore in FY25. It showed a decrease of 1,472.22% on a year-on-year basis.
  • Net Profit: Solara Active Pharma Sci reported a net loss of ₹7.41 crore in FY26 vs ₹0.54 crore in FY25. It showed a decrease of 1,472.22% on a yearly basis.

Solara Active Pharma Sci Quarterly Result Highlights

  • Solara Active Pharma Sci reported revenue of ₹384.29 crore in Jun 2026, compared with ₹391.98 crore in Mar 2026, representing a decrease of 1.96% on a quarter-on-quarter (QoQ) basis.
  • Solara Active Pharma Sci reported an operating profit of ₹16.31 crore in Jun 2026, compared with ₹9.60 crore in Mar 2026, representing an increase of 69.90% on a quarter-on-quarter (QoQ) basis.
  • Solara Active Pharma Sci reported a profit of ₹16.31 crore in Jun 2026, compared with ₹9.60 crore in Mar 2026, reflecting an increase of 69.90% on a QoQ basis.
  • The earnings per share (EPS) of Solara Active Pharma Sci stood at ₹1.68 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
41.93%
FII
11.52%
Other DII
2.79%
Retail and other
42.81%
Mutual funds
0.95%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202511.98%
Mar 202611.59%
May 202611.33%
Jun 202611.52%
Mkt Cap Cr
3,615.16
P/E
-2,257.27
P/B
2.88
ROE
-0.12%
D/E
0.51
ROCE
4.81%
Div. Yield
0.00%
EPS(TTM)
-1.64
Turnover
0.63
EV/EBITDA
22.16
Net Margin
-0.10%
Op. Margin
14.07%
ROA
-0.07%
Quick Ratio
0.55
Curr. Ratio
2.45
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Solara Active outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Solara Active appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Solara Active earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,01,712.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Solara Active Pharma Sci Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,368.98₹1,283.76₹1,288.92₹1,443.81
Other Income₹6.16₹8.32₹5.37₹22.55
Total Revenue₹1,375.14₹1,292.08₹1,294.29₹1,466.36
Total Expenses₹1,376.66₹1,291.54₹1,592.54₹1,511.18
Profit Before Tax-₹7.41₹0.54-₹488.42-₹44.82
Tax₹0.00₹0.00₹78.54-₹22.57
Profit After Tax-₹7.41₹0.54-₹566.96-₹22.25
EPS - Basic-₹1.68₹0.14-₹148.51-₹6.16
EPS - Diluted-₹1.68₹0.14-₹148.51-₹6.16

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹7.41₹0.54-₹488.42-₹44.82
Income before WC changes₹193.20₹210.70-₹82.66₹141.97
Change in Assets-₹79.26₹51.59₹170.45-₹13.16
Change in Liabilities₹41.09-₹48.57₹20.18₹13.90
Change in WC-₹38.17₹3.02₹190.63₹0.74
Cash flow from Operations₹152.91₹212.82₹108.87₹156.25
Cash flow from Investing-₹98.83-₹36.83-₹3.51-₹81.14
Cash flow from Financing-₹53.55-₹180.48-₹105.65-₹112.76
Total Cash Flow₹0.53-₹4.49-₹0.29-₹37.65
Cash (Start of the year)₹3.95₹8.44₹8.73₹46.38
Cash (End of the year)₹4.48₹3.95₹8.44₹8.73

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,474.49₹1,503.11₹1,550.21₹1,711.74
Current Assets₹858.10₹728.73₹800.75₹1,187.54
Total Assets₹2,332.59₹2,231.84₹2,350.96₹2,899.28
Current Liabilities₹893.91₹944.11₹1,242.85₹1,101.13
Net Current Asset-₹35.81-₹215.38-₹442.10₹86.41
Non-Current Liabilities₹183.13₹190.82₹171.53₹295.70
Equity Capital₹1,255.55₹1,096.91₹936.58₹1,502.45
Total Equity & Liabilities₹2,332.59₹2,231.84₹2,350.96₹2,899.28

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,368.98₹1,283.76₹1,288.92₹1,443.81
Other Income₹5.89₹9.14₹5.37₹22.14
Total Revenue₹1,374.87₹1,292.90₹1,294.29₹1,465.95
Total Expenses₹1,376.22₹1,293.98₹1,592.98₹1,510.73
Profit Before Tax-₹7.24-₹1.08-₹488.33-₹44.78
Tax₹0.00₹0.00₹78.54-₹22.57
Profit After Tax-₹7.24-₹1.08-₹566.87-₹22.21
EPS - Basic-₹1.64-₹0.27-₹148.38-₹6.17
EPS - Diluted-₹1.64-₹0.27-₹148.38-₹6.17

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹7.24-₹1.08-₹488.33-₹44.78
Income before WC changes₹193.44₹211.08-₹82.54₹142.10
Change in Assets-₹79.48₹51.51₹172.46-₹15.71
Change in Liabilities₹41.05-₹48.89₹20.11₹16.07
Change in WC-₹38.43₹2.62₹192.57₹0.36
Cash flow from Operations₹152.89₹212.80₹110.95₹156.17
Cash flow from Investing-₹50.14-₹36.83-₹4.66-₹81.13
Cash flow from Financing-₹102.56-₹180.48-₹106.52-₹112.76
Total Cash Flow₹0.19-₹4.51-₹0.23-₹37.72
Cash (Start of the year)₹3.81₹8.32₹8.55₹46.27
Cash (End of the year)₹4.00₹3.81₹8.32₹8.55

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,467.90₹1,496.50₹1,555.95₹1,704.08
Current Assets₹808.69₹728.60₹790.65₹1,190.87
Total Assets₹2,276.59₹2,225.10₹2,346.60₹2,894.95
Current Liabilities₹887.53₹938.07₹1,237.65₹1,096.12
Net Current Asset-₹78.84-₹209.47-₹447.00₹94.75
Non-Current Liabilities₹133.62₹190.82₹171.53₹295.70
Equity Capital₹1,255.44₹1,096.21₹937.42₹1,503.13
Total Equity & Liabilities₹2,276.59₹2,225.10₹2,346.60₹2,894.95
* All values are in INR Crore
Qty
Bid
3154
722.9
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 3154
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
62.82
Neutral
ATR (14)
41.85
Neutral
STOCH(9,6)
51.33
Neutral
STOCH RSI (14)
0
Bullish
ADX(9)
52.52
Bearish
UO(9)
46.21
Neutral
ROC(12)
13.1
Bullish
WillR(14)
-32.97
Neutral
Period
Simple value
Exponential vaue
5D
740.89
733.75
10D
727.87
721.7
20D
685.79
689.18
50D
598.19
629.53
100D
577.52
589.83
Volume trend — traded volume by day
23 Sep4L
22 Sep2L
21 Sep5L
18 Sep2L
17 Sep5L
Average4L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Solara Active Pharma Sci Share Price
Solara Active Pharma Sci
Pharmaceuticals
Add Stock
Add Another

Solara Active Pharma Sci Share Price FAQs

Solara Active Pharma Sci share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837